Kiora Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Notes Receivable (Details Textual)

Stockholders' Notes Receivable (Details Textual) (USD $)	12 Months Ended	24 Months Ended
	Dec. 31, 2012	Dec. 31, 2006	Mar. 31, 2015	Dec. 31, 2014	Oct. 01, 2012
Debt Instrument [Line Items]
Receivable from Shareholders or Affiliates for Issuance of Capital Stock			$ 58,824	$ 58,824
Commercial Paper [Member]
Debt Instrument [Line Items]
Notes Issued		195,000
Debt Instrument, Interest Rate, Effective Percentage					0.93%
Debt Instrument, Maturity Date	Oct. 01, 2016
Receivable from Shareholders or Affiliates for Issuance of Capital Stock			$ 58,824	$ 58,824

- Definition

Amounts due from owners or affiliates of the reporting entity related to issuance of the entity's capital stock before cash payment is received (does not include amounts due from officers or directors). This element would also include the receivable for proceeds from the issuance of shares under employee stock option exercises which proceeds have not been received as of the reporting date due to the timing of the transaction date versus the settlement date.

+ References + Details